Rapid STI test aims to curb antibiotic misuse

NCT ID NCT06369220

First seen Jun 27, 2026 · Last updated Jul 14, 2026 · Updated 2 times

Summary

This study compares a new rapid point-of-care test for chlamydia, gonorrhea, and mycoplasma genitalium to standard lab testing. The goal is to see if the faster test helps doctors give the right antibiotics on the same day, reducing unnecessary or missed treatments. Participants are sexually active people with symptoms or known exposure to an STI.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
cobas® liat CT/NG/MG nucleic acid test
What this could lead to
If successful, this rapid test could help doctors prescribe the right antibiotics on the spot, reducing over- and under-treatment for common sexually transmitted infections.
What could go wrong
The test may not be more accurate than current methods, and its impact on treatment decisions could be limited by practical factors like clinic workflow or cost.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHLAMYDIA TRACHOMATIS INFECTION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Baylor Scott & White Health - Kileen

    Killeen, Texas, 76543, United States

  • Planned Parenthood of Northern, Central and Southern New Jersey

    Perth Amboy, New Jersey, 08861, United States

  • Planned Parenthood of Northern, Central, and Southern New Jersey, Inc.

    Hamilton Square, New Jersey, 08690, United States

  • San Francisco City Clinic

    San Francisco, California, 94103, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.